CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate […]
Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]
According to local reports out of Russia (Moscow Times), the Phase 3 clinical trial investigating Cansino Biologics’ COVID-19 vaccine candidate, […]
At present, there are eight COVID-19 vaccines nearing the end of final trials, and four of these are from China. […]
www.petrocax.com, a Russian pharmaceutical company has inked a deal with CanSino Biologics (CanSinoBIO) to drive Phase 3 clinical trials in Russia. The […]
The Drug Regulatory Authority of Pakistan (DRAP) awarded approval to the National institute of Health (NIH) to embrace CanSino Biologics’ […]
CanSino Biologics was granted the first patent approval from the Chinese government in Beijing for its COVID-19 vaccine called Ad5-nCOV, […]
Canada made the timely move to strike a deal with the Project Lightspeed sponsors Pfizer and BioNTech SE to diversity […]
Just hours after an announcement by Justin Trudeau, Prime Minister of Canada, that the nation’s first COVID-19 vaccine clinical trial […]
China’s CanSino Biologics recently disclosed that the company was advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making […]
